-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $90

Benzinga·07/09/2026 19:07:44
Listen to the news
Jefferies analyst Akash Tewari maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $113 to $90.